Free Trial

Opus Genetics (IRD) Earnings Date, Estimates & Call Transcripts

$1.05 -0.01 (-0.94%)
(As of 03:30 PM ET)

Opus Genetics Latest Earnings Summary

Upcoming
Earnings Date
Mar. 14Estimated
Actual EPS
(Nov. 12)
-$0.29 Beat By $0.01
Consensus EPS
(Nov. 12)
-$0.30

Opus Genetics posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.29, which beat analysts' consensus estimates of -$0.30 by $0.01. Quarterly revenue was reported to be $3.87 million, above analyst estimates of $1.17 million. With a trailing EPS of -$1.09, Opus Genetics' earnings are expected to decrease next year, from ($1.11) to ($1.26) per share.

IRD Upcoming Earnings

Opus Genetics' next earnings date is estimated for Friday, March 14, 2025, based off prior year's reporting schedules.

Get Opus Genetics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Opus Genetics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IRD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Opus Genetics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20241-$0.34-$0.34-$0.34

Opus Genetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/14/2025
(Estimated)
------- 
11/12/2024--$0.30-$0.29+$0.01-$0.29$1.17M$3.87M

Opus Genetics Earnings - Frequently Asked Questions

Opus Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based off last year's report dates. Learn more on IRD's earnings history.

In the previous quarter, Opus Genetics (NASDAQ:IRD) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.01. Learn more on analysts' earnings estimate vs. IRD's actual earnings.

Opus Genetics (NASDAQ:IRD) has a recorded annual revenue of $19.05 million.

Opus Genetics (NASDAQ:IRD) has a recorded net income of -$9.99 million. IRD has generated -$1.09 earnings per share over the last four quarters.

Opus Genetics's earnings are expected to decrease from ($1.11) per share to ($1.26) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:IRD) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners